AtriCure, Inc. (NASDAQ:ATRC – Get Rating) has been assigned an average recommendation of “Buy” from the eleven brokerages that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price target among brokers that […]
Analysts expect AtriCure, Inc. (NASDAQ:ATRC – Get Rating) to report earnings per share of ($0.32) for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for AtriCure’s earnings, with estimates ranging from ($0.36) to ($0.28). AtriCure reported earnings per share of ($0.36) during the same quarter last year, which would […]
AtriCure (NASDAQ:ATRC – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Tuesday. ATRC has been the topic of several other reports. Canaccord Genuity Group lowered their price target on AtriCure from $120.00 to $88.00 and set a “buy” rating on the stock in a […]
Equities research analysts predict that AtriCure, Inc. (NASDAQ:ATRC – Get Rating) will announce earnings per share of ($0.27) for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for AtriCure’s earnings. The highest EPS estimate is ($0.18) and the lowest is ($0.36). AtriCure reported earnings of ($0.38) per share during the […]
Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Rating) have been given an average recommendation of “Buy” by the thirteen research firms that are covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target […]